These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 18159695)

  • 1. [Heparinemia (anti-factor Xa activity].
    Emile C
    Rev Infirm; 2007 Nov; (135):49-50. PubMed ID: 18159695
    [No Abstract]   [Full Text] [Related]  

  • 2. Factor Xa inhibition.
    Bramlage P; Pittrow D; Kirch W
    Eur J Clin Invest; 2005 Mar; 35 Suppl 1():1-3. PubMed ID: 15701141
    [No Abstract]   [Full Text] [Related]  

  • 3. Heparin therapy and monitoring: a role for the chromogenic antifactor Xa assay.
    Rosén S; Casoni MC
    Am Clin Lab; 2001 Aug; 20(7):35-8. PubMed ID: 11570272
    [No Abstract]   [Full Text] [Related]  

  • 4. Heparin and low-molecular-weight heparin.
    Gray E; Mulloy B; Barrowcliffe TW
    Thromb Haemost; 2008 May; 99(5):807-18. PubMed ID: 18449410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DU-176b, an oral, direct Factor Xa antagonist.
    Hylek E
    Curr Opin Investig Drugs; 2007 Sep; 8(9):778-83. PubMed ID: 17729190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral anticoagulants--the old and the new.
    Ansell J
    Dis Mon; 2005; 51(2-3):208-12. PubMed ID: 15900274
    [No Abstract]   [Full Text] [Related]  

  • 7. [Venous thromboembolism].
    Konstantinides S
    Dtsch Med Wochenschr; 2006 Jun; 131(24):1389-400; quiz 1401-2. PubMed ID: 16783673
    [No Abstract]   [Full Text] [Related]  

  • 8. Recurrent venous thromboembolism: quite harmless after all?
    Konstantinides SV
    Thromb Haemost; 2008 Apr; 99(4):655-6. PubMed ID: 18392321
    [No Abstract]   [Full Text] [Related]  

  • 9. [New antithrombotic principles approaching clinical use].
    Bergqvist D
    Lakartidningen; 2004 Feb; 101(8):646-7. PubMed ID: 15024937
    [No Abstract]   [Full Text] [Related]  

  • 10. [Update on anticoagulant therapy].
    Gensini GF; Falciani M; Dilaghi B; Poli D
    Cardiologia; 1999 Dec; 44 Suppl 1(Pt 2):673-80. PubMed ID: 12497803
    [No Abstract]   [Full Text] [Related]  

  • 11. Disorders of pulmonary circulation.
    Pineo GF; Hull RD
    Curr Opin Pulm Med; 2008 Sep; 14(5):365-8. PubMed ID: 18664963
    [No Abstract]   [Full Text] [Related]  

  • 12. An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases.
    Melo FR; Mourão PA
    Thromb Haemost; 2008 Mar; 99(3):531-8. PubMed ID: 18327401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
    Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulant treatment of deep vein thrombosis and pulmonary embolism.
    Tran H; McRae S; Ginsberg J
    Cardiol Clin; 2008 May; 26(2):235-50, vi-vii. PubMed ID: 18406997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
    van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR
    Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In brief. Thromboembolic disease.
    Wakefield TW; Caprini J; Comerota AJ
    Curr Probl Surg; 2008 Dec; 45(12):838-42. PubMed ID: 18984094
    [No Abstract]   [Full Text] [Related]  

  • 17. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?
    Fareed J; Iqbal O; Cunanan J; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deep venous thrombosis and pulmonary thromboembolism: evolving concepts and controversies. Preface.
    Tapson VF
    Semin Respir Crit Care Med; 2008 Feb; 29(1):1-2. PubMed ID: 18302081
    [No Abstract]   [Full Text] [Related]  

  • 19. Monitoring high-dose heparinization during cardiopulmonary by-pass--a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assays.
    Raivio P; Kuitunen A; Petäjä J; Ilveskero S; Lassila R
    Thromb Haemost; 2008 Feb; 99(2):427-34. PubMed ID: 18278195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venous thromboembolism prophylaxis and treatment in patients with acute stroke and traumatic brain injury.
    Vergouwen MD; Roos YB; Kamphuisen PW
    Curr Opin Crit Care; 2008 Apr; 14(2):149-55. PubMed ID: 18388676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.